The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
The clinical consequences of antimicrobial resistance
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316 · cited 1×
“They both use several mechanisms, including the expression of chromosomally encoded broad-spectrum b-lactamases, multidrug efflux pumps and slow or disappearing outer membrane channels (porins) to allow rapid adjustment to ongoing antimicrobial challenges [50].”
BackgroundKlevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726 · cited 1×
“This situation has now changed with astonishing rapidity across the globe with the emergence and spread of community-associated MRSA (CA-MRSA) [11,12 ].”
BackgroundHidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
The Changing Epidemiology of Staphylococcus aureus?
Chambers, H. F. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010204 · Cited by 1,495
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494 · cited 2×
“In contrast to the previously much more common TEM-type and SHV-type extended-spectrum b-lactamases (ESBLs), CTX-M enzymes tend to have greater activity against ceftriaxone than ceftazidime [18].”
BackgroundResultKyaw, M. H., Lynfield, R., Schaffner, W., Craig, A. S., Hadler, J., Reingold, A., Thomas, A. R., Harrison, L. H., Bennett, N. M., Farley, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051642 · Cited by 881
Community-Acquired Bacterial Meningitis in Adults
van de Beek, D., de Gans, J., Tunkel, A. R., & Wijdicks, E. F. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052116 · Cited by 880
Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii
Fournier, P.-E., Vallenet, D., Barbe, V., Audic, S., Ogata, H., Poirel, L., Richet, H., Robert, C., Mangenot, S., Abergel, C., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020007 · Cited by 812
Staphylococcus aureus Panton-Valentine Leukocidin Causes Necrotizing Pneumonia
Labandeira-Rey, M., Couzon, F., Boisset, S., Brown, E. L., Bes, M., Benito, Y., Barbu, E. M., Vazquez, V., Höök, M., Etienne, J., et al. (2007) · Science · doi:10.1126/science.1137165 · Cited by 709
Seybold, U., Kourbatova, E. V., Johnson, J. G., Halvosa, S. J., Wang, Y. F., King, M. D., Ray, S. M., & Blumberg, H. M. (2006) · Clinical Infectious Diseases · doi:10.1086/499815 · Cited by 695
Antimicrobial resistance of Staphylococcus aureus: genetic basis
Lyon, B. R., & Skurray, R. A. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.1.88-134.1987 · Cited by 686
van den Bogaard, A. E. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.6.763 · Cited by 622
Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins
Meyer, K. S., Urban, C., Eagan, J. A., Berger, B. J., & Rahal, J. J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-5-199309010-00001 · Cited by 580
Global Spread of Vancomycin-resistant Enterococcus faecium from Distinct Nosocomial Genetic Complex
Willems, R. J. L., Top, J., van Santen, M., Robinson, D. A., Coque, T. M., Baquero, F., Grundmann, H., & Bonten, M. J. M. (2005) · Emerging Infectious Diseases · doi:10.3201/1106.041204 · Cited by 558
Manges, A. R., Johnson, J. R., Foxman, B., O'Bryan, T. T., Fullerton, K. E., & Riley, L. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011265 · Cited by 531
Skin and Soft-Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus
Daum, R. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp070747 · Cited by 417
Tristan, A., Bes, M., Meugnier, H., Lina, G., Bozdogan, B., Courvalin, P., Reverdy, M.-E., Enright, M. C., Vandenesch, F., & Etienne, J. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1304.061316 · Cited by 410
Gupta, K., Sahm, D. F., Mayfield, D., & Stamm, W. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320880 · Cited by 359
Willems, R. J., Homan, W., Top, J., van Santen-Verheuvel, M., Tribe, D., Manzioros, X., Gaillard, C., Vandenbroucke-Grauls, C. M., Mascini, E. M., van Kregten, E., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04205-7 · Cited by 327
Vergis, E. N., Hayden, M. K., Chow, J. W., Snydman, D. R., Zervos, M. J., Linden, P. K., Wagener, M. M., Schmitt, B., & Muder, R. R. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-7-200110020-00007 · Cited by 319
Rice, L. B., Eckstein, E. C., DeVente, J., & Shlaes, D. M. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.1.118 · Cited by 313
Self-citationEmergence of Vancomycin-Resistant Enterococci
Rice, L. B. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010205 · Cited by 277
Self-citationWegener, H. C., Aarestrup, F. M., Jensen, L. B., Hammerum, A. M., & Bager, F. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0503.990303 · Cited by 265
Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen
Top, J., Willems, R., & Bonten, M. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00383.x · Cited by 260
Schiappa, D. A., Hayden, M. K., Matushek, M. G., Hashemi, F. N., Sullivan, J., Smith, K. Y., Miyashiro, D., Quinn, J. P., Weinstein, R. A., & Trenholme, G. M. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.3.529 · Cited by 248
Miller, L. G., Remington, F. P., Bayer, A. S., Diep, B., Tan, N., Bharadwa, K., Tsui, J., Perlroth, J., Shay, A., Tagudar, G., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511033 · Cited by 246
Charlebois, E. D., Bangsberg, D. R., Moss, N. J., Moore, M. R., Moss, A. R., Chambers, H. F., & Perdreau-Remington, F. (2002) · Clinical Infectious Diseases · doi:10.1086/338069 · Cited by 245 · cited 1×
“For many years, MRSA remained a problem restricted to hospitals and other health care-associated settings [10].”
BackgroundVan der Auwera, P., Pensart, N., Korten, V., Murray, B. E., & Leclercq, R. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/173.5.1129 · Cited by 237
Lewis, J. S., Herrera, M., Wickes, B., Patterson, J. E., & Jorgensen, J. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00576-07 · Cited by 231
Leavis, H. L., Willems, R. J. L., van Wamel, W. J. B., Schuren, F. H., Caspers, M. P. M., & Bonten, M. J. M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030007 · Cited by 215
Sahm, D. F., Marsilio, M. K., & Piazza, G. (1999) · Clinical Infectious Diseases · doi:10.1086/520195 · Cited by 213
Rice, L. B. (2008) · Clinical Infectious Diseases · doi:10.1086/526535 · Cited by 200
Self-citationDagan, R., Givon‐Lavi, N., Leibovitz, E., Greenberg, D., & Porat, N. (2009) · The Journal of Infectious Diseases · doi:10.1086/597044 · Cited by 188
Navon-Venezia, S., Leavitt, A., Schwaber, M. J., Rasheed, J. K., Srinivasan, A., Patel, J. B., & Carmeli, Y. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00987-08 · Cited by 170
Cagnacci, S., Gualco, L., Debbia, E., Schito, G. C., & Marchese, A. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00640-08 · Cited by 166
First Report of KPC-2-Producing Klebsiella pneumoniae Strains in Brazil
Monteiro, J., Santos, A. F., Asensi, M. D., Peirano, G., & Gales, A. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00736-08 · Cited by 158
Crespo, M., Woodford, N., Sinclair, A., Kaufmann, M. E., Turton, J. F., Glover, J., Vélez, J. D., Castañeda-Ramirez, C. R., Recalde, M. P., & Livermore, D. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5094-5101.2004 · Cited by 153
Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom
Woodford, N., Zhang, J., Warner, M., Kaufmann, M. E., Matos, J., MacDonald, A., Brudney, D., Sompolinsky, D., Navon‐Venezia, S., & Livermore, D. M. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn396 · Cited by 149
Talbot, T. R., Poehling, K. A., Hartert, T. V., Arbogast, P. G., Halasa, N., Ed, M., Schaffner, W., Craig, A. S., Edwards, K. M., & Griffin, M. R. (2004) · Clinical Infectious Diseases · doi:10.1086/422653 · Cited by 134
Enterococcal Endocarditis: A Comparison of Prosthetic and Native Valve Disease
Rice, L. B., Calderwood, S. B., Eliopoulos, G. M., Farber, B. F., & Karchmer, A. W. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/13.1.1 · Cited by 116
Self-citationEpidemiology of extended spectrum β-lactamases
Philippon, A., Redjeb, S. B., Hassen, A. B., & Fournier, G. (1989) · Infection · doi:10.1007/bf01650727 · Cited by 111
Lee, J., Patel, G., Huprikar, S. S., Calfee, D. P., & Jenkins, S. G. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02466-08 · Cited by 110
The Decline of Methicillin Resistance Among Danish Staphylococcus Aureus Strains
Rosdahl, V. T., & Knudsen, A. M. (1991) · Infection Control and Hospital Epidemiology · doi:10.1086/646291 · Cited by 102
Castanheira, M., Mendes, R. E., Rhomberg, P. R., & Jones, R. N. (2008) · Microbial Drug Resistance · doi:10.1089/mdr.2008.0827 · Cited by 88
Descheemaeker, P. R. M., Chapelle, S., Devriese, L. A., Butaye, P., Vandamme, P. A. R., & Goossens, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.2032 · Cited by 81
Ciprofloxacin-Resistant Gram-Negative Bacilli in the Fecal Microflora of Children
Qin, X. G., Razia, Y., Johnson, J. R., Stapp, J. R., Boster, D. R., Tsosie, T., Smith, D. L., Braden, C. R., Gay, K., Angulo, F. J., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00548-06 · Cited by 64
Pneumococcal vaccine development
POOLMAN, J. T. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.5.597 · Cited by 62
Glycopeptide-Resistant Enterococcus faecium Outside Hospitals: A Commentary
Witte, W., & Klare, I. (1995) · Microbial Drug Resistance · doi:10.1089/mdr.1995.1.259 · Cited by 51
Whither antibacterial drug discovery?
Projan, S. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.03.010 · Cited by 32
Cited by
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Huh, A. J., & Kwon, Y. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.002 · Cited by 1,864
Selection of Resistant Bacteria at Very Low Antibiotic Concentrations
Gullberg, E., Cao, S., Berg, O. G., Ilbäck, C., Sandegren, L., Hughes, D., & Andersson, D. I. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002158 · Cited by 1,654
Antimicrobial resistance: A global emerging threat to public health systems
Ferri, M., Ranucci, E., Romagnoli, P., & Giaccone, V. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1077192 · Cited by 1,049
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 836
Metadata
- Authors
- Rice, L. B.
- Venue
- Current Opinion in Microbiology
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 12
- Issue
- 5
- Pages
- 476-481
- ISSN
- 1369-5274 (ISSN-L)
- OpenAlex
- W2052566690
- Cited by
- 291
- References
- 50
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.